Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials
β Scribed by F. Fabrizi; S. V. Ganeshan; G. Lunghi; P. Messa; P. Martin
- Book ID
- 108886145
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 63 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The efficacy and safety of pegylated interferon monotherapy in patients with chronic renal failure and chronic hepatitis C remains unclear, although a number of small clinical trials have been published addressing this issue. A systematic review of the literature with a metaβanalysis of
## Abstract The characteristics and response rate to pegylated interferon and ribavirin (PEGβINFβ+βRBV) of patients with chronic hepatitis C infected with genotype 5 are poorly documented. A metaβanalysis of two large phase III/IV prospective randomized clinical trials conducted in Belgium in patie
In patients with chronic hepatitis C, advanced fibrosis and cirrhosis are associated with lower rates of sustained virologic response (SVR) to interferon (IFN)-based therapy. In this study, we assessed virologic response to retreatment with peginterferon alfa-2a and ribavirin (RBV), as a function of